Clinical trial results should not be interpreted as on a simple binary axis of success or failure, a pair of review articles in the New England Journal of Medicine's "The Changing Face of Clinical Trials" series argues.
The "unreasonable yet widespread practice" of labeling randomized trials as positive or negative based on the p-value of the primary...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?